4.49 USD
↗ 0.14 (3.22%)AT CLOSE (11:59 AM EDT)
Atea Pharmaceuticals, Inc. Common Stock
AVIRNASDAQ • USD
4.37
↘ 0.12 (2.67%)
POST MARKET (AS OF 04:32 PM EDT)
Post Market
AS OF 04:32 PM EDT
4.37
↘ 0.12 (2.67%)
Market: CLOSED
Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $4.49 per share. AVIR shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, AVIR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 26, 2026.
Open?$4.35
High?$4.52
Low?$4.34
Prev. Close?$4.35
Volume?1.2M
Avg. Volume?342.3K
VWAP?$4.46
Rel. Volume?3.64x
Bid / Ask
Bid?$3.62 × 100
Ask?$5.17 × 100
Spread?$1.55
Midpoint?$4.40
Valuation & Ratios
Market Cap?359.3M
Shares Out?80.0M
Float?54.5M
Float %?69.8%
P/E Ratio?N/A
P/B Ratio?1.54
EPS?-$2.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Employees
55
Market Cap
348.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-10-30
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Phone: (857) 284-8891
BOSTON, MA 02110
Phone: (857) 284-8891
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?41
Momentum?23
Short Sent.?33
Piotroski F-Score?0/9Weak
Altman Z-Score?2.17Grey
Confidence?60%Moderate
Short InterestVery High
Short % of Float?12.97%High
Short Interest?7.1M
Days to Cover?28.9
Free Float54.5M
Avg Daily Volume244.8K
Settlement Date2026-06-15
Financial Health
Current Ratio?7.89Strong
Quick Ratio?7.89Strong
Cash Ratio?2.38Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.54CHEAP▾
Peers100
S&P86
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-72.5%WEAK▾
S&P3
ROA?-63.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$280.0M
Fundamentals ratios updated end of day